Boehringer to sell generic pharma business for $2.65B

By Danielle Brody

1 Comment

Ridgefield-based Boehringer Ingelheim will sell its generic pharmaceutical businesses for approximately $2.65 billion.

This content is for Westfair Online members only. Please login to view this content. Become a member by Registering Here. If you would prefer to start with a 12 week free trial, Click Here.


About the author

Danielle Brody
Danielle is the events manager for Westfair Communications. Previously, she was a reporter for the Fairfield and Westchester County Business Journals. She has written for the Journal News, the Scarsdale Inquirer and the Newark Post. Danielle is a graduate of the University of Delaware.

Related Articles